Document
Effects of Classic Ketogenic Diet in Children with Refractory Epilepsy : A Retrospective Cohort Study in Kingdom of Bahrain
Linked Agent
Ferraris, C, Author
Guglielmetti, M, Author
Alalwan, T.A, Author
Mahdi, A.M, Author
Guido, D, Author
Tagliabue, A., Author
Title of Periodical
Nutrients
Country of Publication
Kingdom of Bahrain
Place Published
sakhir
Publisher
University of Bahrain
Date Issued
2022
Language
English
English Abstract
Abstract:
Background: The classic ketogenic diet (cKD) has been used worldwide as an effective
therapy for children with drug-resistant epilepsy. However, there have been no studies performed
in Middle Eastern countries in order to assess the efficacy, side effects, predictors of cKD response
and factors mostly associated with diet adherence. This study aims to assess the efficacy of cKD
ratios of 4:1 and 3:1 and their influence on growth and biochemical parameters, particularly lipid
profile and liver function tests (LFTs), and the factors most associated with diet adherence in a
cohort of children with drug-resistant epilepsy in Bahrain. Methods: Baseline and follow-up data
related to patients’ demographic and biochemical variables, epilepsy episodes, diet history and
anthropometric measurements were retrieved for a total of 24 children treated with cKD in Bahrain.
Results: After 6 months cKD initiation, 58.3% were positive responders with >50% seizure rate
reduction, and 33.3% became seizure-free at 12 months. After 6 months of intervention with cKD,
the level of triglycerides and albumin had a significant (p < 0.05) average increase over time of
+1.47 mmol/L and 4.3 g/L, respectively. Although the median values of total cholesterol and alanine
transaminase increased, respectively, following cKD initiation, the difference over time was not
statistically significant. The mean z-scores for weight, height, and body mass index (or weight-forlength) did not change significantly at 12 months follow-up. cKD duration was the highest correlated
variable with cKD efficacy (r = 0.76), which was followed by age at cKD initiation (r = 0.47). The
cKD was discontinued by 14 patients (58.3%) during the first follow-up period (6 months), which
was mainly due to inefficacy (n = 8), poor compliance (n = 3), food refusal (n = 1), achieved required
efficacy (n = 1) and death (n = 1). Conclusions: cKD is an effective treatment for patients with drugresistant epilepsy, and positive response to cKD was the main factor that increased adherence to
the diet. Although long-term cKD could increase the risk of dyslipidemia and hepatic problems,
it appears safe for children. Consequently, close monitoring and emphasis on healthy fats is of
high priority
Member of
Identifier
https://digitalrepository.uob.edu.bh/id/e640129e-5e68-4abf-a489-ccfebc2768e3